FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.)
• Description:
  On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. Cervarix is the second human papillomavirus (HPV) vaccine licensed for use in females in the United States. Quadrivalent HPV vaccine (HPV4; Gardasil, Merck & Co, Inc.) was licensed in 2006 for use in females aged 9 through 26 years, and the Advisory Committee on Immunization Practices (ACIP) recommended routine HPV4 vaccination of females aged 11 or 12 years, and catch-up vaccination for females aged 13 through 26 years (1). This report provides updated recommendations for routine and catch-up vaccination of females with either HPV2 or HPV4.
• Subjects:
  Adolescent Adult Antibody Formation Child Female Human Papillomavirus 16 Human Papillomavirus 18 Humans Immunization Schedule Licensure Papillomavirus Infections Papillomavirus Vaccines Randomized Controlled Trials As Topic Uterine Cervical Neoplasms Young Adult

  More +
• Source:
  MMWR. Morbidity and mortality weekly report. 2010; 59(20):626-9.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  20508593
• Document Type:
  Journal Article
• Name as Subject:
  United States. Food and Drug Administration. ; United States. Food and Drug Administration.
• Place as Subject:
  United States
• Pages in Document:
  4 pdf pages
• Volume:
  59
• Issue:
  20
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:3445807cf59a04fb508d187e47844dfdf1e2e489e3ee089d047f62f0f92c151214933de7c2652475661667d4d82ad0b01ad7c4b8b8e9bdce1600985984970ce8
• Download URL:
  https://stacks.cdc.gov/view/cdc/7333/cdc_7333_DS1.pdf
• File Type:
  [PDF - 1.33 MB ]